CBD, short for cannabidiol, is one of the cannabinoids found in cannabis. It does not produce the characteristic THC high, but it can affect the body and interact with medicines. A product being plant-derived does not make it harmless or suitable for every person.
The most useful distinction is between a defined prescription medicine, tested for a particular condition, and the many oils, cosmetics and other products sold under the CBD label. Evidence for one preparation cannot simply be transferred to all the others.
What medical use has been established?
In the United States, the FDA has approved the purified CBD medicine Epidiolex for seizures associated with Lennox–Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex in patients aged one year and older. That is a specific medicine with specific indications and medical supervision. It is not approval of ordinary CBD oils for every form of epilepsy or of CBD as a cancer treatment. FDA information on cannabis-derived medicines.
Approval in one country also does not establish a product's registration or permitted sale in Thailand. Check the Thai classification of the actual product rather than relying on a foreign approval, a hemp logo or a seller's assurance.
What about pain, sleep, anxiety and cancer?
These are different clinical questions. An experiment showing an effect in cells or animals does not demonstrate that a retail CBD preparation treats a disease in people. Nor does an account of feeling calmer establish a treatment for an anxiety disorder.
Ask whether the evidence concerns CBD alone, THC with CBD, or another preparation; which patients took part; and what benefit and harms were measured. Our guides to cannabis and sleep and mental-health evidence explain those distinctions. Do not replace prescribed treatment on the strength of a product description.
CBD can cause side effects
The FDA identifies risks including liver injury, medicine interactions, sleepiness and gastrointestinal effects. Some problems may require clinical monitoring rather than being obvious to the person taking the product. FDA consumer guidance on CBD.
Before considering CBD, give the treating professional a complete list of prescription medicines, non-prescription medicines and supplements. Mention alcohol use and any previous unwanted reaction to cannabis products. This is more useful than asking whether CBD is “natural.” Do not assume a topical, edible and oral oil have interchangeable effects or instructions.
What to check on a product
| Check | Why it matters |
|---|---|
| Exact product and manufacturer | Identifies what is being assessed, rather than a general brand claim |
| CBD amount and units | Distinguishes concentration from the total contents of a bottle |
| THC information | A CBD label does not establish the absence of THC |
| Ingredients and route | Oils, cosmetics and medicines have different formulations and intended uses |
| Batch-linked testing | Connects a report to the actual product; check the tests and their limits |
| Thai product status | Foreign labels and approvals do not settle the local regulatory question |
For example, an amount stated for a whole bottle is different from an amount per millilitre. Ask for clarification if a label is ambiguous; do not estimate a treatment dose from marketing copy. A laboratory report can describe the tested sample but cannot establish that the product will help your condition.
Spectrum labels need their own checks
Full-spectrum, broad-spectrum and isolate describe intended composition. They do not rank medical effectiveness or guarantee the result of a drug test. Read our CBD spectrum-label guide before treating those terms as a decision rule.
If you are seeking care in Thailand, bring the product label and your treatment question to an appropriately qualified professional. Our prescription guide explains the assessment process without promising approval.
Corrected 6 September 2026. We withdrew earlier claims that CBD has no side effects, treats cancer, or should replace medicines because it is herbal.
